| Page 2 of 3 < > |
Health Highlights: Sept. 6, 2008
|
Discussion Policy
Comments that include profanity or personal attacks or other inappropriate comments or material will be removed from the site. Additionally, entries that are unsigned or contain "signatures" by someone other than the actual author will be removed. Finally, we will take steps to block users who violate any of our posting standards, terms of use or privacy policies or any other policies governing this site. Please review the full rules governing commentaries and discussions. You are fully responsible for the content that you post.
|
The men in the study ate a calorie-reduce diet with two variations of protein intake -- 11 to 14 percent or 18 to 25 percent of daily calories. Both were within U.S. nutrition recommendations for normal protein intake,UPIreported.
-----
Nicotine May Enhance Other Experiences: Study
The way nicotine enhances other experiences may have something to do with its addictive quality, according to a Kansas State University study in the journalNeuropsychopharmacology.
Most research on nicotine focuses on the drug itself, rather than other aspects such as social factors, noted lead author Matthew Palmatier,United Press Internationalreported.
"People have very regimented things they do when they smoke," Palmatier said in a news release. "People smoke in very specific places, often with a specific group of people. Maybe it's a reason why nicotine is so addictive -- if you get used to having that extra satisfaction from things you normally enjoy, not having nicotine could reduce the enjoyment in a given activity."
He said it's necessary to look at the big picture in order to better understand why people smoke, even though most of them are fully aware of the health risks
"(Smokers) want to quit but can't. It's not because nicotine is a potent drug; it doesn't induce significant amounts of pleasure or euphoria. Yet, it's just as difficult, if not more difficult, to quit than other drugs," said Palmatier,UPIreported.
-----
Fablyn Increases Risk of Blood Clots: FDA Document
While the new osteoporosis drug Fablyn has been shown to be effective in postmenopausal women with a higher risk of bone fractures, the drug also increased the risk of blood clots and invasive gynecological visits, says a U.S. Food and Drug Administration advisory board briefing document released Thursday.
The document was made public in advance of the advisory board's scheduled Monday meeting to decide whether to recommend approval of the drug,Forbesreported.



